Europital board forewarns that clinical deficits to slow biotech development in 2021
Ghent (Belgium), 08 February 2021: The newly formed Scientific Advisory Board (SAB) of Europital – a globally-focused, full-service CRO serving small and mid-tier innovators – forewarns that a clinical knowledge deficit amongst smaller biotechs will potentially slow trials in 2021.
More info >> |